# The underlying mechanism behind the different outcomes of COVID-19 in children and adults

**Authors:** Zifang Shang, Ling Huang, Shijie Qin

PMC · DOI: 10.3389/fimmu.2025.1440169 · Frontiers in Immunology · 2025-04-30

## TL;DR

This paper reviews why children are less affected by COVID-19 than adults, focusing on biological and immune differences.

## Contribution

The paper systematically reviews protective mechanisms in children against severe COVID-19, highlighting immune and metabolic factors.

## Key findings

- Children show lower ACE2 and TMPRSS2 expression, potentially reducing SARS-CoV-2 entry.
- Children's immune responses include stronger interferon activity and better heterologous protection from prior vaccines.
- Age-related differences in cytokine profiles and micronutrient levels may contribute to milder disease in children.

## Abstract

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has affected hundreds of millions of people globally, resulting in millions of deaths. During this pandemic, children have demonstrated greater resistance than adults, exhibiting lower infection rates, reduced mortality, and milder symptoms. Summarizing the differences in resistance between children and adults during COVID-19 can provide insights into protective mechanisms and potential implications for future treatments. In this review, we focused on summarizing and discussing the mechanisms for better protection of children in COVID-19. These protective mechanisms encompass several factors: the baseline expression of cell surface receptor ACE2 and hydrolase TMPRSS2, the impact of complications on COVID-19, and age-related cytokine profiles. Additionally, differences in local and systemic immune responses between children and adults also contribute significantly, particularly interferon responses, heterologous protection from non-COVID-19 vaccinations, and immune status variations influenced by micronutrient levels. The advantageous protection mechanisms of these children may provide insights into the prevention and treatment of COVID-19. Importantly, while age-related metabolic profiles and differential COVID-19 vaccine responses may contribute to protection in children, current comparative research remains limited and requires further investigation.

## Linked entities

- **Genes:** ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272], TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113]
- **Diseases:** Coronavirus disease 2019 (MONDO:0100096), COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, NEU1 (neuraminidase 1) [NCBI Gene 4758] {aka NANH, NEU, SIAL1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FURIN (furin, paired basic amino acid cleaving enzyme) [NCBI Gene 5045] {aka FUR, PACE, PCSK3, SPC1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, KLRC1 (killer cell lectin like receptor C1) [NCBI Gene 3821] {aka CD159A, NKG2, NKG2A}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, ORF1 [NCBI Gene 55354], CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, IFIH1 (interferon induced with helicase C domain 1) [NCBI Gene 64135] {aka AGS7, Hlcd, IDDM19, IMD95, MDA-5, MDA5}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113] {aka PRSS10}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IL1RN (interleukin 1 receptor antagonist) [NCBI Gene 3557] {aka CRMO2, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3}, RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** rash (MESH:D005076), vascular damage (MESH:D057772), lung cancer (MESH:D008175), myocarditis (MESH:D009205), nutritional deficiencies (MESH:D044342), obesity (MESH:D009765), inflammatory storm (MESH:C566109), COPD (MESH:D029424), MIS (MESH:C000705967), hepatic or renal dysfunction (MESH:D008107), chronic diseases (MESH:D002908), oral polio (MESH:D011051), tetanus (MESH:D013746), pertussis (MESH:D014917), fatigue (MESH:D005221), headache (MESH:D006261), coagulation abnormalities (MESH:D001778), rhinorrhea (MESH:D012818), hearing impairment (MESH:D034381), tuberculosis (MESH:D014376), endothelial dysfunction (MESH:D014652), hypotension (MESH:D007022), viral disease (MESH:D014777), loss of smell (MESH:D000086582), dyspnea (MESH:D004417), Hyperglycemia (MESH:D006943), MIS-N (MESH:D056587), fever (MESH:D005334), lung injury (MESH:D055370), nausea/vomiting (MESH:D020250), gastrointestinal symptoms (MESH:D012817), cough (MESH:D003371), organ failure (MESH:D009102), diabetes (MESH:D003920), acute respiratory syndromes (MESH:D012120), myalgia (MESH:D063806), measles (MESH:D008457), thymic suppression (MESH:D013953), sore throat (MESH:D010612), influenza (MESH:D007251), runny nose and sore throat (MESH:D000086722), septic shock (MESH:D012772), respiratory infections (MESH:D012141), vomiting (MESH:D014839), Kawasaki (MESH:D009080), lung damage (MESH:D008171), Adult COVID-19 (MESH:D000086382), hypertension (MESH:D006973), shock (MESH:D012769), diphtheria (MESH:D004165), systemic (MESH:D015619), rubella (MESH:D012409), bacterial infections (MESH:D001424), ARDS (MESH:D012128), zinc deficiency (MESH:C564286), tachycardia (MESH:D013610), colon and lung (MESH:D015179), hypercoagulability (MESH:D019851), coronary atherosclerosis (MESH:D003324), death (MESH:D003643)
- **Chemicals:** Vitamin D (MESH:D014807), Zinc (MESH:D015032), Bacille (-), 1,5-Anhydro-D-glucitol (MESH:C006584), phosphorus (MESH:D010758), 8-OHdG (MESH:D000080242), calcium (MESH:D002118), NO (MESH:D009569)
- **Species:** Measles morbillivirus (no rank) [taxon 11234], Orthomyxoviridae (family) [taxon 11308], Human coronavirus HKU1 (no rank) [taxon 290028], Homo sapiens (human, species) [taxon 9606], Human coronavirus NL63 (no rank) [taxon 277944], Respiratory syncytial virus (no rank) [taxon 12814], Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], H1N1 subtype (serotype) [taxon 114727], Human coronavirus OC43 (no rank) [taxon 31631]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12075420/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12075420/full.md

## References

135 references — full list in the complete paper: https://tomesphere.com/paper/PMC12075420/full.md

---
Source: https://tomesphere.com/paper/PMC12075420